Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Stephen Harvey Zinner, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01HL033221 (ZINNER, STEPHEN H) Sep 30, 1984 - Sep 29, 1988
    NIH/NHLBI
    SALT TASTE AND OTHER CORRELATES OF INFANT BLOOD PRESSURE
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Golikova MV, Strukova EN, Portnoy YA, Zinner SH, Firsov AA. Predicting the antistaphylococcal effects of daptomycin-rifampicin combinations in an in vitro dynamic model. J Antibiot (Tokyo). 2020 Feb; 73(2):101-107. PMID: 31624338.
    Citations:    
  2. Golikova MV, Strukova EN, Portnoy YA, Dovzhenko SA, Kobrin MB, Zinner SH, Firsov AA. A novel parameter to predict the effects of antibiotic combinations on the development of Staphylococcus aureus resistance: in vitro model studies at subtherapeutic daptomycin and rifampicin exposures. J Chemother. 2019 Jul 17; 1-9. PMID: 31314704.
    Citations:    
  3. Golikova MV, Strukova EN, Portnoy YA, Dovzhenko SA, Kobrin MB, Zinner SH, Firsov AA. Resistance studies with Streptococcus pneumoniae using an in vitro dynamic model: amoxicillin versus azithromycin at clinical exposures. J Chemother. 2019 Sep; 31(5):252-260. PMID: 31179907.
    Citations:    
  4. Tulkens PM, Van Bambeke F, Zinner SH. Profile of a Novel Anionic Fluoroquinolone-Delafloxacin. Clin Infect Dis. 2019 04 08; 68(Suppl 3):S213-S222. PMID: 30957164.
    Citations:    
  5. Alieva KN, Golikova MV, Portnoy YA, Dovzhenko SA, Kobrin MB, Zinner SH, Firsov AA. Concentration-dependent enrichment of resistant Enterococcus faecium exposed to linezolid in an in vitro dynamic model. J Chemother. 2018 Oct - Dec; 30(6-8):364-370. PMID: 30663551.
    Citations:    Fields:    
  6. Zinner SH, Golikova MV, Strukova EN, Portnoy YA, Firsov AA. Predicting antibiotic combination effects on the selection of resistant Staphylococcus aureus: In vitro model studies with linezolid and gentamicin. Int J Antimicrob Agents. 2018 Dec; 52(6):854-860. PMID: 30236953.
    Citations:    Fields:    
  7. Alieva KN, Strukova EN, Golikova MV, Portnoy YA, Zinner SH, Firsov AA. Time inside the mutant selection window as a predictor of staphylococcal resistance to linezolid. J Antibiot (Tokyo). 2018 05; 71(5):514-521. PMID: 29348530.
    Citations:    Fields:    
  8. Firsov AA, Alieva KN, Strukova EN, Golikova MV, Portnoy YA, Dovzhenko SA, Kobrin MB, Romanov AV, Edelstein MV, Zinner SH. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model. J Antimicrob Chemother. 2017 Nov 01; 72(11):3100-3107. PMID: 28981793.
    Citations:    Fields:    Translation:HumansCells
  9. Tillotson GS, Zinner SH. Burden of antimicrobial resistance in an era of decreasing susceptibility. Expert Rev Anti Infect Ther. 2017 07; 15(7):663-676. PMID: 28580804.
    Citations: 5     Fields:    Translation:Humans
  10. Strukova EN, Portnoy YA, Zinner SH, Firsov AA. Species differences in ciprofloxacin resistance among Gram-negative bacteria: can "anti-mutant" ratios of the area under the concentration-time curve to the MIC be achieved clinically? J Chemother. 2017 Dec; 29(6):351-357. PMID: 28587559.
    Citations:    Fields:    Translation:HumansCells
  11. Golikova MV, Strukova EN, Portnoy YA, Dovzhenko SA, Kobrin MB, Zinner SH, Firsov AA. Predicting effects of antibiotic combinations using MICs determined at pharmacokinetically derived concentration ratios: in vitro model studies with linezolid- and rifampicin-exposed Staphylococcus aureus. J Chemother. 2017 Oct; 29(5):267-273. PMID: 28192070.
    Citations:    Fields:    Translation:HumansCells
  12. Firsov AA, Golikova MV, Strukova EN, Portnoy YA, Dovzhenko SA, Kobrin MB, Zinner SH. Pharmacokinetically-based prediction of the effects of antibiotic combinations on resistant Staphylococcus aureus mutants: in vitro model studies with linezolid and rifampicin. J Chemother. 2017 Aug; 29(4):220-226. PMID: 27748167.
    Citations: 2     Fields:    Translation:HumansCells
  13. Rapoport B, Klastersky J, Raftopoulos H, Freifeld A, Aoun M, Zinner SH, Rolston KV. The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC "Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013. Support Care Cancer. 2016 07; 24(7):2819-26. PMID: 27098065.
    Citations: 1     Fields:    Translation:Humans
  14. Strukova EN, Portnoy YA, Romanov AV, Edelstein MV, Zinner SH, Firsov AA. Searching for the Optimal Predictor of Ciprofloxacin Resistance in Klebsiella pneumoniae by Using In Vitro Dynamic Models. Antimicrob Agents Chemother. 2015 Dec 07; 60(3):1208-15. PMID: 26643328.
    Citations:    Fields:    Translation:Cells
  15. Strukova EN, Portnoy YA, Zinner SH, Firsov AA. Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration. J Antimicrob Chemother. 2016 Mar; 71(3):678-84. PMID: 26626718.
    Citations: 1     Fields:    Translation:HumansCells
  16. Firsov AA, Strukova EN, Portnoy YA, Shlykova DS, Zinner SH. Bacterial antibiotic resistance studies using in vitro dynamic models: Population analysis vs. susceptibility testing as endpoints of mutant enrichment. Int J Antimicrob Agents. 2015 Sep; 46(3):313-8. PMID: 26297633.
    Citations: 1     Fields:    Translation:HumansCells
  17. Tillotson GS, Zinner SH. Antibiotic Development and the Evolving Role of Pharmacodynamics - As Good as It Gets? EBioMedicine. 2015 Jul; 2(7):615-6. PMID: 26288824.
    Citations:    Fields:    Translation:HumansCells
  18. Firsov AA, Golikova MV, Strukova EN, Portnoy YA, Romanov AV, Edelstein MV, Zinner SH. In vitro resistance studies with bacteria that exhibit low mutation frequencies: prediction of "antimutant" linezolid concentrations using a mixed inoculum containing both susceptible and resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2015 Feb; 59(2):1014-9. PMID: 25451050.
    Citations: 4     Fields:    Translation:Cells
  19. Firsov AA, Portnoy YA, Strukova EN, Shlykova DS, Zinner SH. Predicting bacterial resistance using the time inside the mutant selection window: possibilities and limitations. Int J Antimicrob Agents. 2014 Oct; 44(4):301-5. PMID: 25218155.
    Citations: 3     Fields:    Translation:Cells
  20. Firsov AA, Strukova EN, Shlykova DS, Portnoy YA, Kozyreva VK, Edelstein MV, Dovzhenko SA, Kobrin MB, Zinner SH. Bacterial resistance studies using in vitro dynamic models: the predictive power of the mutant prevention and minimum inhibitory antibiotic concentrations. Antimicrob Agents Chemother. 2013 Oct; 57(10):4956-62. PMID: 23896481.
    Citations: 7     Fields:    Translation:Cells
  21. Tillotson GS, Zinner SH. Paul Ehrlich, a prescient pioneer in the field of antimicrobial chemotherapy: what did he foresee a century ago? Expert Rev Anti Infect Ther. 2013 Feb; 11(2):113-5. PMID: 23409816.
    Citations:    Fields:    Translation:PHPublic Health
  22. Zinner SH, Gilbert D, Greer K, Portnoy YA, Firsov AA. Concentration-resistance relationships with Pseudomonas aeruginosa exposed to doripenem and ciprofloxacin in an in vitro model. J Antimicrob Chemother. 2013 Apr; 68(4):881-7. PMID: 23175594.
    Citations: 4     Fields:    Translation:HumansCells
  23. Firsov AA, Gilbert D, Greer K, Portnoy YA, Zinner SH. Comparative pharmacodynamics and antimutant potentials of doripenem and imipenem with ciprofloxacin-resistant Pseudomonas aeruginosa in an in vitro model. Antimicrob Agents Chemother. 2012 Mar; 56(3):1223-8. PMID: 22203591.
    Citations: 1     Fields:    Translation:HumansCells
  24. Smirnova MV, Strukova EN, Portnoy YA, Dovzhenko SA, Kobrin MB, Zinner SH, Firsov AA. The antistaphylococcal pharmacodynamics of linezolid alone and in combination with doxycycline in an in vitro dynamic model. J Chemother. 2011 Jun; 23(3):140-4. PMID: 21742582.
    Citations: 2     Fields:    Translation:Cells
  25. Smirnova MV, Vostrov SN, Strukova EV, Dovzhenko SA, Kobrin MB, Portnoy YA, Zinner SH, Firsov AA. The impact of duration of antibiotic exposure on bacterial resistance predictions using in vitro dynamic models. J Antimicrob Chemother. 2009 Oct; 64(4):815-20. PMID: 19671586.
    Citations: 5     Fields:    Translation:HumansCells
  26. Strukova EN, Smirnova MV, Vostrov SN, Lubenko IY, Firsov AA, Zinner SH, Portnoy YA. Linezolid pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model. Int J Antimicrob Agents. 2009 Mar; 33(3):251-4. PMID: 19095420.
    Citations: 2     Fields:    Translation:Cells
  27. Firsov AA, Smirnova MV, Strukova EN, Vostrov SN, Portnoy YA, Zinner SH. Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion. Int J Antimicrob Agents. 2008 Dec; 32(6):488-93. PMID: 18790614.
    Citations: 5     Fields:    Translation:Cells
  28. Lubenko IY, Strukova EV, Smirnova MV, Vostrov SN, Portnoy YA, Zinner SH, Firsov AA. Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model. J Antimicrob Chemother. 2008 Nov; 62(5):1065-9. PMID: 18635520.
    Citations: 4     Fields:    Translation:Cells
  29. Firsov AA, Lubenko IY, Smirnova MV, Strukova EN, Zinner SH. Enrichment of fluoroquinolone-resistant Staphylococcus aureus: oscillating ciprofloxacin concentrations simulated at the upper and lower portions of the mutant selection window. Antimicrob Agents Chemother. 2008 Jun; 52(6):1924-8. PMID: 18378704.
    Citations: 9     Fields:    Translation:HumansCells
  30. Zinner SH, Gilbert D, Lubenko IY, Greer K, Firsov AA. Selection of linezolid-resistant Enterococcus faecium in an in vitro dynamic model: protective effect of doxycycline. J Antimicrob Chemother. 2008 Mar; 61(3):629-35. PMID: 18245198.
    Citations: 6     Fields:    Translation:HumansCells
  31. Zinner SH. Antibiotic use: present and future. New Microbiol. 2007 Jul; 30(3):321-5. PMID: 17802919.
    Citations: 5     Fields:    Translation:HumansCells
  32. Zinner SH, Firsov A. Antibiotic pharmacodynamics and bacterial resistance: usefulness of in vitro models. Curr Infect Dis Rep. 2007 May; 9(3):175-7. PMID: 17430696.
    Citations:    
  33. Smirnova MV, Lubenko IY, Portnoy YA, Zinner SH, Firsov AA. Concentration-response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model. Int J Antimicrob Agents. 2007 Feb; 29(2):165-9. PMID: 17207607.
    Citations: 1     Fields:    Translation:Cells
  34. Firsov AA, Smirnova MV, Lubenko IY, Vostrov SN, Portnoy YA, Zinner SH. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model. J Antimicrob Chemother. 2006 Dec; 58(6):1185-92. PMID: 17028094.
    Citations: 19     Fields:    Translation:Cells
  35. Cometta A, Marchetti O, Calandra T, Bille J, Kern WV, Zinner S. In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients. Eur J Clin Microbiol Infect Dis. 2006 Aug; 25(8):537-40. PMID: 16896825.
    Citations: 2     Fields:    Translation:HumansCells
  36. Zinner SH. The search for new antimicrobials: why we need new options. Expert Rev Anti Infect Ther. 2005 Dec; 3(6):907-13. PMID: 16307503.
    Citations: 4     Fields:    Translation:HumansAnimals
  37. Alferova IV, Vostrov SN, Portnoy YA, Lubenko IY, Zinner SH, Firsov AA. Comparative pharmacodynamics of telithromycin and clarithromycin with Streptococcus pneumoniae and Staphylococcus aureus in an in vitro dynamic model: focus on clinically achievable antibiotic concentrations. Int J Antimicrob Agents. 2005 Sep; 26(3):197-204. PMID: 16122914.
    Citations:    Fields:    Translation:Cells
  38. Zinner SH. Overview of antibiotic use and resistance: setting the stage for tigecycline. Clin Infect Dis. 2005 Sep 01; 41 Suppl 5:S289-92. PMID: 16080067.
    Citations:    Fields:    Translation:Humans
  39. Firsov AA, Lubenko IY, Vostrov SN, Portnoy YA, Zinner SH. Antistaphylococcal effect related to the area under the curve/MIC ratio in an in vitro dynamic model: predicted breakpoints versus clinically achievable values for seven fluoroquinolones. Antimicrob Agents Chemother. 2005 Jul; 49(7):2642-7. PMID: 15980331.
    Citations: 7     Fields:    Translation:HumansCells
  40. Firsov AA, Alferova IV, Smirnova MV, Lubenko IY, Portnoy YA, Zinner SH. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and levofloxacin with Streptococcus pneumoniae in an in vitro dynamic model. Int J Antimicrob Agents. 2005 May; 25(5):409-13. PMID: 15848296.
    Citations: 2     Fields:    Translation:HumansCells
  41. Zinner SH. Fluoroquinolone prophylaxis in patients with neutropenia. Clin Infect Dis. 2005 Apr 15; 40(8):1094-5. PMID: 15791506.
    Citations:    Fields:    Translation:Humans
  42. Zinner SH, Vostrov SN, Alferova IV, Lubenko IY, Portnoy YA, Firsov AA. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model. Int J Antimicrob Agents. 2004 Aug; 24(2):173-7. PMID: 15288317.
    Citations: 3     Fields:    Translation:HumansCells
  43. Firsov AA, Vostrov SN, Lubenko IY, Arzamastsev AP, Portnoy YA, Zinner SH. ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model. J Antimicrob Chemother. 2004 Jul; 54(1):178-86. PMID: 15190041.
    Citations: 6     Fields:    Translation:HumansCells
  44. Firsov AA, Vostrov SN, Lubenko IY, Portnoy YA, Zinner SH. Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model: an additive effect of the combination. Int J Antimicrob Agents. 2004 May; 23(5):451-6. PMID: 15120722.
    Citations: 7     Fields:    Translation:Cells
  45. Firsov AA, Vostrov SN, Lubenko IY, Zinner SH, Portnoy YA. Concentration-dependent changes in the susceptibility and killing of Staphylococcus aureus in an in vitro dynamic model that simulates normal and impaired gatifloxacin elimination. Int J Antimicrob Agents. 2004 Jan; 23(1):60-6. PMID: 14732315.
    Citations: 5     Fields:    Translation:HumansCells
  46. Zinner SH, Lubenko IY, Gilbert D, Simmons K, Zhao X, Drlica K, Firsov AA. Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing. J Antimicrob Chemother. 2003 Oct; 52(4):616-22. PMID: 12951352.
    Citations: 17     Fields:    Translation:Cells
  47. Cometta A, Kern WV, De Bock R, Paesmans M, Vandenbergh M, Crokaert F, Engelhard D, Marchetti O, Akan H, Skoutelis A, Korten V, Vandercam M, Gaya H, Padmos A, Klastersky J, Zinner S, Glauser MP, Calandra T, Viscoli C. Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy. Clin Infect Dis. 2003 Aug 01; 37(3):382-9. PMID: 12884163.
    Citations: 14     Fields:    Translation:HumansCTClinical Trials
  48. Firsov AA, Vostrov SN, Lubenko IY, Drlica K, Portnoy YA, Zinner SH. In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus. Antimicrob Agents Chemother. 2003 May; 47(5):1604-13. PMID: 12709329.
    Citations: 48     Fields:    Translation:Cells
  49. Firsov AA, Zinner SH, Vostrov SN, Portnoy YA, Lubenko IY. AUC/MIC relationships to different endpoints of the antimicrobial effect: multiple-dose in vitro simulations with moxifloxacin and levofloxacin. J Antimicrob Chemother. 2002 Oct; 50(4):533-9. PMID: 12356798.
    Citations: 6     Fields:    Translation:HumansCells
  50. Portnoy YA, Vostrov SN, Lubenko IY, Zinner SH, Firsov AA. Species-independent pharmacodynamics of gemifloxacin and ciprofloxacin with Haemophilus influenzae and Moraxella catarrhalis in an in vitro dynamic model. Int J Antimicrob Agents. 2002 Sep; 20(3):201-5. PMID: 12385699.
    Citations:    Fields:    Translation:HumansCells
  51. Zinner SH, McGarvey ST, Lipsitt LP, Rosner B. Neonatal blood pressure and salt taste responsiveness. Hypertension. 2002 Sep; 40(3):280-5. PMID: 12215467.
    Citations:    Fields:    Translation:Humans
  52. Lubenko IY, Vostrov SN, Portnoy YA, Zinner SH, Firsov AA. Bacterial strain-independent AUC/MIC and strain-specific dose-response relationships reflecting comparative fluoroquinolone anti-pseudomonal pharmacodynamics in an in vitro dynamic model. Int J Antimicrob Agents. 2002 Jul; 20(1):44-9. PMID: 12127710.
    Citations: 1     Fields:    Translation:Cells
  53. Firsov AA, Zinner SH, Vostrov SN, Kononenko OV, Portnoy YA, Shustova LV, Kadenatsi IB. Comparative pharmacodynamics of azithromycin and roxithromycin with S. pyogenes and S. pneumoniae in a model that simulates in vitro pharmacokinetics in human tonsils. J Antimicrob Chemother. 2002 Jan; 49(1):113-9. PMID: 11751774.
    Citations: 2     Fields:    Translation:HumansCells
  54. Firsov AA, Zinner SH, Lubenko IY, Portnoy YA, Vostrov SN. Simulated in vitro quinolone pharmacodynamics at clinically achievable AUC/MIC ratios: advantage of I E over other integral parameters. Chemotherapy. 2002; 48(6):275-9. PMID: 12673102.
    Citations:    Fields:    Translation:Cells
  55. Zinner SH, Firsov AA, Gilbert D, Simmons K, Lubenko IY. The pharmacodynamics of gatifloxacin and ciprofloxacin for pneumococci in an in vitro dynamic model: prediction of equiefficient doses. J Antimicrob Chemother. 2001 Dec; 48(6):821-6. PMID: 11733466.
    Citations: 2     Fields:    Translation:HumansCells
  56. Zinner SH, Vostrov SN, Lubenko IY, Portnoy YA, Cornaglia G, Firsov AA. Comparative anti-staphylococcal effects of gemifloxacin and trovafloxacin in an in vitro dynamic model in terms of AUC/MIC and dose relationships. Diagn Microbiol Infect Dis. 2001 Aug; 40(4):167-71. PMID: 11576789.
    Citations:    Fields:    Translation:Cells
  57. Firsov AA, Lubenko IY, Portnoy YA, Zinner SH, Vostrov SN. Relationships of the area under the curve/MIC ratio to different integral endpoints of the antimicrobial effect: gemifloxacin pharmacodynamics in an in vitro dynamic model. Antimicrob Agents Chemother. 2001 Mar; 45(3):927-31. PMID: 11181382.
    Citations: 3     Fields:    Translation:HumansCells
  58. Firsov AA, Zinner SH. Use of Modeling Techniques to Aid in Antibiotic Selection. Curr Infect Dis Rep. 2001 Feb; 3(1):35-43. PMID: 11177729.
    Citations: 3     
  59. Firsov AA, Zinner SH, Vostrov SN. Gemifloxacin and ciprofloxacin pharmacodynamics in an in-vitro dynamic model: prediction of the equivalent AUC/MIC breakpoints and doses. Int J Antimicrob Agents. 2000 Dec; 16(4):407-14. PMID: 11118849.
    Citations: 2     Fields:    Translation:HumansCells
  60. Firsov AA, Lubenko IY, Vostrov SN, Kononenko OV, Zinner SH, Portnoy YA. Comparative pharmacodynamics of moxifloxacin and levofloxacin in an in vitro dynamic model: prediction of the equivalent AUC/MIC breakpoints and equiefficient doses. J Antimicrob Chemother. 2000 Nov; 46(5):725-32. PMID: 11062191.
    Citations: 7     Fields:    Translation:HumansCells
  61. Zinner SH. New pathogens in neutropenic patients with cancer: an update for the new millennium. Int J Antimicrob Agents. 2000 Oct; 16(2):97-101. PMID: 11053787.
    Citations:    Fields:    Translation:HumansAnimalsCells
  62. Vostrov SN, Kononenko OV, Lubenko IY, Zinner SH, Firsov AA. Comparative pharmacodynamics of gatifloxacin and ciprofloxacin in an in vitro dynamic model: prediction of equiefficient doses and the breakpoints of the area under the curve/MIC ratio. Antimicrob Agents Chemother. 2000 Apr; 44(4):879-84. PMID: 10722485.
    Citations: 4     Fields:    Translation:HumansCells
  63. Zinner SH, Simmons K, Gilbert D. Comparative activities of ciprofloxacin and levofloxacin against Streptococcus pneumoniae in an In vitro dynamic model. Antimicrob Agents Chemother. 2000 Mar; 44(3):773-4. PMID: 10681356.
    Citations: 1     Fields:    Translation:HumansCells
  64. Zinner SH, Firsov AA. In vitro dynamic model for determining the comparative pharmacology of fluoroquinolones. Am J Health Syst Pharm. 1999 Nov 15; 56(22 Suppl 3):S12-5. PMID: 10580735.
    Citations:    Fields:    Translation:Humans
  65. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis. 1999 Sep; 29(3):490-4. PMID: 10530434.
    Citations: 58     Fields:    Translation:HumansCellsPHPublic Health
  66. Firsov AA, Vasilov RG, Vostrov SN, Kononenko OV, Lubenko IY, Zinner SH. Prediction of the antimicrobial effects of trovafloxacin and ciprofloxacin on staphylococci using an in-vitro dynamic model. J Antimicrob Chemother. 1999 Apr; 43(4):483-90. PMID: 10350376.
    Citations: 6     Fields:    Translation:HumansCells
  67. Firsov AA, Vostrov SN, Kononenko OV, Zinner SH, Portnoy YA. Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model. Antimicrob Agents Chemother. 1999 Mar; 43(3):498-502. PMID: 10049257.
    Citations: 6     Fields:    Translation:Cells
  68. Firsov AA, Vostrov SN, Shevchenko AA, Portnoy YA, Zinner SH. A new approach to in vitro comparisons of antibiotics in dynamic models: equivalent area under the curve/MIC breakpoints and equiefficient doses of trovafloxacin and ciprofloxacin against bacteria of similar susceptibilities. Antimicrob Agents Chemother. 1998 Nov; 42(11):2841-7. PMID: 9797213.
    Citations: 9     Fields:    Translation:HumansCells
  69. Firsov AA, Vostrov SN, Shevchenko AA, Zinner SH, Cornaglia G, Portnoy YA. MIC-based interspecies prediction of the antimicrobial effects of ciprofloxacin on bacteria of different susceptibilities in an in vitro dynamic model. Antimicrob Agents Chemother. 1998 Nov; 42(11):2848-52. PMID: 9797214.
    Citations: 6     Fields:    Translation:HumansCells
  70. Zinner SH. Relevant aspects in the Infectious Diseases Society of America (IDSA) guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Int J Hematol. 1998 Oct; 68 Suppl 1:S31-4. PMID: 9838742.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  71. Firsov AA, Shevchenko AA, Vostrov SN, Zinner SH. Inter- and intraquinolone predictors of antimicrobial effect in an in vitro dynamic model: new insight into a widely used concept. Antimicrob Agents Chemother. 1998 Mar; 42(3):659-65. PMID: 9517948.
    Citations: 18     Fields:    Translation:Cells
  72. Stoupis A, Zinner SH. Approach to fever in the neutropenic host. Cancer Treat Res. 1998; 96:77-104. PMID: 9711396.
    Citations:    Fields:    Translation:Humans
  73. Zinner SH, Gilbert D, Dudley MN. Activity of trovafloxacin (with or without ampicillin-sulbactam) against enterococci in an in vitro dynamic model of infection. Antimicrob Agents Chemother. 1998 Jan; 42(1):72-7. PMID: 9449263.
    Citations: 3     Fields:    Translation:Cells
  74. Zinner SH, McCormack WM. Three decades of research on sexual behavior and sexually transmitted pathogens in college students. Med Health R I. 1997 Oct; 80(10):338-40. PMID: 9350120.
    Citations:    Fields:    Translation:Humans
  75. Peipert JF, Domagalski L, Boardman L, Daamen M, McCormack WM, Zinner SH. Sexual behavior and contraceptive use. Changes from 1975 to 1995 in college women. J Reprod Med. 1997 Oct; 42(10):651-7. PMID: 9350021.
    Citations: 1     Fields:    Translation:Humans
  76. Firsov AA, Ruble M, Gilbert D, Saverino D, Savarino D, Manzano B, Medeiros AA, Zinner SH. Net effect of inoculum size on antimicrobial action of ampicillin-sulbactam: studies using an in vitro dynamic model. Antimicrob Agents Chemother. 1997 Jan; 41(1):7-12. PMID: 8980746.
    Citations: 2     Fields:    Translation:Cells
  77. Peipert JF, Domagalski L, Boardman L, Daamen M, Zinner SH, McCormack WM. College women and condom use, 1975-1995. N Engl J Med. 1996 Jul 18; 335(3):211. PMID: 8657236.
    Citations:    Fields:    Translation:Humans
  78. Cometta A, Calandra T, Gaya H, Zinner SH, de Bock R, Del Favero A, Bucaneve G, Crokaert F, Kern WV, Klastersky J, Langenaeken I, Micozzi A, Padmos A, Paesmans M, Viscoli C, Glauser MP. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program. Antimicrob Agents Chemother. 1996 May; 40(5):1108-15. PMID: 8723449.
    Citations: 37     Fields:    Translation:HumansCTClinical Trials
  79. Firsov AA, Saverino D, Savarino D, Ruble M, Gilbert D, Manzano B, Medeiros AA, Zinner SH. Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC. Antimicrob Agents Chemother. 1996 Mar; 40(3):734-8. PMID: 8851602.
    Citations: 13     Fields:    Translation:Cells
  80. Ruble MW, Gilbert DH, Zinner SH. In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria. Clin Microbiol Infect. 1996 Mar; 1(3):183-189. PMID: 11866755.
    Citations:    Fields:    
  81. Cometta A, Zinner S, de Bock R, Calandra T, Gaya H, Klastersky J, Langenaeken J, Paesmans M, Viscoli C, Glauser MP. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Antimicrob Agents Chemother. 1995 Feb; 39(2):445-52. PMID: 7726513.
    Citations: 31     Fields:    Translation:HumansCTClinical Trials
  82. Zinner SH. New and unusual infections in neutropenic patients. Cancer Treat Res. 1995; 79:173-84. PMID: 8746654.
    Citations:    Fields:    Translation:HumansCells
  83. Strayer AH, Gilbert DH, Pivarnik P, Medeiros AA, Zinner SH, Dudley MN. Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection. Antimicrob Agents Chemother. 1994 Oct; 38(10):2351-6. PMID: 7840569.
    Citations: 19     Fields:    Translation:Cells
  84. McCormack WM, Zinner SH, McCormack WM. The incidence of genitourinary infections in a cohort of healthy women. Sex Transm Dis. 1994 Mar-Apr; 21(2):63-4. PMID: 9071413.
    Citations: 3     Fields:    Translation:Humans
  85. Viscoli C, Bruzzi P, Castagnola E, Boni L, Calandra T, Gaya H, Meunier F, Feld R, Zinner S, Klastersky J, et al. Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer. 1994; 30A(4):430-7. PMID: 8018397.
    Citations: 22     Fields:    Translation:Humans
  86. Marchbanks CR, McKiel JR, Gilbert DH, Robillard NJ, Painter B, Zinner SH, Dudley MN. Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection. Antimicrob Agents Chemother. 1993 Sep; 37(9):1756-63. PMID: 8239581.
    Citations: 15     Fields:    Translation:Humans
  87. Zinner SH. New pathogens in the immunocompromised host. Recent Results Cancer Res. 1993; 132:231-40. PMID: 8265865.
    Citations:    Fields:    Translation:HumansAnimalsCells
  88. Browne MJ, Mayer KH, Chafee SB, Dudley MN, Posner MR, Steinberg SM, Graham KK, Geletko SM, Zinner SH, Denman SL, et al. 2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial. J Infect Dis. 1993 Jan; 167(1):21-9. PMID: 8093363.
    Citations: 30     Fields:    Translation:HumansCellsCTClinical Trials
  89. Dudley MN, Blaser J, Gilbert D, Mayer KH, Zinner SH. Combination therapy with ciprofloxacin plus azlocillin against Pseudomonas aeruginosa: effect of simultaneous versus staggered administration in an in vitro model of infection. J Infect Dis. 1991 Sep; 164(3):499-506. PMID: 1908000.
    Citations: 10     Fields:    Translation:Cells
  90. Meunier F, Zinner SH, Gaya H, Calandra T, Viscoli C, Klastersky J, Glauser M. Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group. Antimicrob Agents Chemother. 1991 May; 35(5):873-8. PMID: 1854169.
    Citations: 22     Fields:    Translation:HumansCTClinical Trials
  91. Dudley MN, Zinner SH. Single daily dosing of amikacin in an in-vitro model. J Antimicrob Chemother. 1991 May; 27 Suppl C:15-9. PMID: 1906862.
    Citations: 6     Fields:    Translation:Cells
  92. McGarvey ST, Zinner SH, Willett WC, Rosner B. Maternal prenatal dietary potassium, calcium, magnesium, and infant blood pressure. Hypertension. 1991 Feb; 17(2):218-24. PMID: 1991654.
    Citations: 10     Fields:    Translation:Humans
  93. Marchbanks CR, Mikolich DJ, Mayer KH, Zinner SH, Dudley MN. Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections. Antimicrob Agents Chemother. 1990 Oct; 34(10):1966-72. PMID: 2291662.
    Citations: 2     Fields:    Translation:Humans
  94. Schlaeffer F, Blaser J, Laxon J, Zinner S. Enhancement of leucocyte killing of resistant bacteria selected during exposure to aminoglycosides or quinolones. J Antimicrob Chemother. 1990 Jun; 25(6):941-8. PMID: 2115038.
    Citations: 4     Fields:    Translation:HumansCells
  95. DeBuono BA, Zinner SH, Daamen M, McCormack WM. Sexual behavior of college women in 1975, 1986, and 1989. N Engl J Med. 1990 Mar 22; 322(12):821-5. PMID: 2308616.
    Citations: 24     Fields:    Translation:Humans
  96. Glatt AE, Zinner SH, McCormack WM. The prevalence of dyspareunia. Obstet Gynecol. 1990 Mar; 75(3 Pt 1):433-6. PMID: 2304713.
    Citations: 5     Fields:    Translation:Humans
  97. Zinner SH, Scheld WM. Brief review of fungal infections. Pharmacotherapy. 1990; 10(6 ( Pt 3)):146S-149S. PMID: 2075113.
    Citations:    Fields:    Translation:HumansAnimals
  98. Dudley MN, Blaser J, Gilbert D, Zinner SH. Significance of "extravascular" protein binding for antimicrobial pharmacodynamics in an in vitro capillary model of infection. Antimicrob Agents Chemother. 1990 Jan; 34(1):98-101. PMID: 2327764.
    Citations: 13     Fields:    Translation:Cells
  99. Zinner S. Fosfomycin trometamol versus pipemidic acid in the treatment of bacteriuria in pregnancy. Chemotherapy. 1990; 36 Suppl 1:50-2. PMID: 2085991.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  100. McGarvey ST, Zinner SH. Blood pressure in infancy. Semin Nephrol. 1989 Sep; 9(3):260-6. PMID: 2675245.
    Citations:    Fields:    Translation:Humans
  101. Dudley MN, Mandler HD, Mayer KH, Zinner SH. Serum inhibitory and bactericidal activity of ciprofloxacin following intravenous administration. DICP. 1989 Jun; 23(6):456-60. PMID: 2741478.
    Citations: 1     Fields:    Translation:HumansCells
  102. Zinner SH. Clinical overview of enoxacin. Clin Pharmacokinet. 1989; 16 Suppl 1:59-64. PMID: 2653698.
    Citations: 1     Fields:    Translation:Humans
  103. Zinner SH, Dudley MN, Gilbert D, Bassignani M. Effect of dose and schedule on cefoperazone pharmacodynamics in an in vitro model of infection in a neutropenic host. Am J Med. 1988 Jul 25; 85(1A):56-8. PMID: 3400681.
    Citations: 4     Fields:    Translation:Cells
  104. McCormack WM, Starko KM, Zinner SH. Symptoms associated with vaginal colonization with yeast. Am J Obstet Gynecol. 1988 Jan; 158(1):31-3. PMID: 3337178.
    Citations: 4     Fields:    Translation:HumansAnimals
  105. Klastersky J, Zinner SH, Calandra T, Gaya H, Glauser MP, Meunier F, Rossi M, Schimpff SC, Tattersall M, Viscoli C. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials. Eur J Cancer Clin Oncol. 1988; 24 Suppl 1:S35-45. PMID: 3280326.
    Citations: 22     Fields:    Translation:HumansCellsCTClinical Trials
  106. Calandra T, Klastersky J, Gaya H, Glauser MP, Meunier F, Zinner SH. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med. 1987 12 31; 317(27):1692-8. PMID: 2892130.
    Citations: 49     Fields:    Translation:HumansCellsCTClinical Trials
  107. Dudley MN, Ericson J, Zinner SH. Effect of dose on serum pharmacokinetics of intravenous ciprofloxacin with identification and characterization of extravascular compartments using noncompartmental and compartmental pharmacokinetic models. Antimicrob Agents Chemother. 1987 Nov; 31(11):1782-6. PMID: 3435125.
    Citations: 8     Fields:    Translation:Humans
  108. Blaser J, Stone BB, Groner MC, Zinner SH. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrob Agents Chemother. 1987 Jul; 31(7):1054-60. PMID: 3116917.
    Citations: 126     Fields:    Translation:Cells
  109. Dudley MN, Mandler HD, Gilbert D, Ericson J, Mayer KH, Zinner SH. Pharmacokinetics and pharmacodynamics of intravenous ciprofloxacin. Studies in vivo and in an in vitro dynamic model. Am J Med. 1987 Apr 27; 82(4A):363-8. PMID: 3555061.
    Citations: 13     Fields:    Translation:Humans
  110. Blaser J, Zinner SH. In vitro models for the study of antibiotic activities. Prog Drug Res. 1987; 31:349-81. PMID: 3326034.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  111. Zinner SH, Dudley MN. Bactericidal activity of ciprofloxacin alone and in combination with azlocillin in an in-vitro capillary model. J Antimicrob Chemother. 1986 Nov; 18 Suppl D:49-54. PMID: 3100491.
    Citations: 2     Fields:    Translation:Cells
  112. Zinner SH, Dudley M, Blaser J. In vitro models for the study of combination antibiotic therapy in neutropenic patients. Am J Med. 1986 Jun 30; 80(6B):156-60. PMID: 3728526.
    Citations: 5     Fields:    Translation:Humans
  113. Zinner SH, Blaser J. In vitro models in the study of antibiotic therapy of infections in neutropenic patients. Am J Med. 1986 May 30; 80(5C):40-4. PMID: 3717188.
    Citations:    Fields:    Translation:Humans
  114. Zinner SH, Blaser J, Gaya H. Laboratory support for choosing and monitoring antimicrobial therapy in severely ill patients. Am J Med. 1986 May 30; 80(5C):59-63. PMID: 3717189.
    Citations:    Fields:    Translation:Humans
  115. Blaser J, Dudley MN, Gilbert D, Zinner SH. Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin. Antimicrob Agents Chemother. 1986 May; 29(5):927-9. PMID: 2942102.
    Citations: 13     Fields:    Translation:Cells
  116. McCormack WM, Rosner B, Alpert S, Evrard JR, Crockett VA, Zinner SH. Vaginal colonization with mycoplasma hominis and ureaplasma urealyticum. Sex Transm Dis. 1986 Apr-Jun; 13(2):67-70. PMID: 3715677.
    Citations: 8     Fields:    Translation:HumansCells
  117. Zinner SH, Blaser J. In-vitro studies of antibiotic combinations with special emphasis on the evaluation of newly developed methods. J Antimicrob Chemother. 1986 Mar; 17 Suppl A:1-5. PMID: 3086275.
    Citations: 1     Fields:    Translation:Cells
  118. Klastersky J, Glauser MP, Schimpff SC, Zinner SH, Gaya H. Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients. Antimicrob Agents Chemother. 1986 Feb; 29(2):263-70. PMID: 3521475.
    Citations: 27     Fields:    Translation:HumansCellsCTClinical Trials
  119. Zinner SH. Review of amikacin usage in the EORTC trials. Am J Med. 1985 Jul 15; 79(1A):17-20. PMID: 3895903.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  120. Blaser J, Stone BB, Groner MC, Zinner SH. Impact of netilmicin regimens on the activities of ceftazidime-netilmicin combinations against Pseudomonas aeruginosa in an in vitro pharmacokinetic model. Antimicrob Agents Chemother. 1985 Jul; 28(1):64-8. PMID: 3929682.
    Citations: 11     Fields:    Translation:HumansCells
  121. Mayer KH, Zinner SH. Bacterial pathogens of increasing significance in hospital-acquired infections. Rev Infect Dis. 1985 Jul-Aug; 7 Suppl 3:S371-9. PMID: 3901204.
    Citations: 3     Fields:    Translation:Humans
  122. Zinner SH, Rosner B, Oh W, Kass EH. Significance of blood pressure in infancy. Familial aggregation and predictive effect on later blood pressure. Hypertension. 1985 May-Jun; 7(3 Pt 1):411-6. PMID: 3997223.
    Citations: 21     Fields:    Translation:Humans
  123. Blaser J, Stone BB, Zinner SH. Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model. Antimicrob Agents Chemother. 1985 Mar; 27(3):343-9. PMID: 3922294.
    Citations: 26     Fields:    Translation:HumansCells
  124. McCormack WM, Rosner B, McComb DE, Evrard JR, Zinner SH. Infection with Chlamydia trachomatis in female college students. Am J Epidemiol. 1985 Jan; 121(1):107-15. PMID: 3964985.
    Citations: 19     Fields:    Translation:HumansCells
  125. Blaser J, Stone BB, Zinner SH. Two compartment kinetic model with multiple artificial capillary units. J Antimicrob Chemother. 1985 Jan; 15 Suppl A:131-7. PMID: 3980324.
    Citations: 38     Fields:    Translation:Humans
  126. Zinner SH, Blaser J, Stone BB, Groner MC. Use of an in-vitro kinetic model to study antibiotic combinations. J Antimicrob Chemother. 1985 Jan; 15 Suppl A:221-6. PMID: 3920181.
    Citations: 6     Fields:    Translation:Cells
  127. Ampel NM, Keating MH, Moon-McDermott L, Peter G, Zinner SH. Comparison of tube dilution and microtitre methods for the detection of antibiotic tolerance in strains of Staphylococcus aureus. J Antimicrob Chemother. 1984 May; 13(5):417-21. PMID: 6564128.
    Citations: 9     Fields:    Translation:Cells
  128. Ampel NM, Moon-McDermott L, Keating M, Zinner SH. In-vitro activity of aztreonam in combination with four other antibiotics against gram-negative bacilli and Staphylococcus aureus. J Antimicrob Chemother. 1984 Apr; 13(4):398-9. PMID: 6539326.
    Citations: 3     Fields:    Translation:Cells
  129. Zinner SH. Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future. Schweiz Med Wochenschr Suppl. 1983; 14:7-14. PMID: 6361995.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  130. Zinner SH, Lagast H, Kasry A, Klastersky J. Synergism of trimethoprim combined with aminoglycosides in vitro and in serum of volunteers. Eur J Clin Microbiol. 1982 Jun; 1(3):144-8. PMID: 7173179.
    Citations: 1     Fields:    Translation:HumansCells
  131. Klastersky J, Zinner SH. Synergistic combinations of antibiotics in gram-negative bacillary infections. Rev Infect Dis. 1982 Mar-Apr; 4(2):294-301. PMID: 7051232.
    Citations: 36     Fields:    Translation:HumansAnimals
  132. Zinner SH, Husson M, Klastersky J. An artificial capillary in vitro kinetic model of antibiotic bactericidal activity. J Infect Dis. 1981 Dec; 144(6):583-7. PMID: 6799585.
    Citations: 6     Fields:    Translation:Cells
  133. Zinner SH, Lagast H, Klastersky J. Antistaphylococcal activity of rifampin with other antibiotics. J Infect Dis. 1981 Oct; 144(4):365-71. PMID: 6270215.
    Citations: 24     Fields:    Translation:HumansCells
  134. Zinner SH, Klastersky J, Gaya H, Bernard C, Ryff JC. In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureus. Antimicrob Agents Chemother. 1981 Oct; 20(4):463-9. PMID: 6282192.
    Citations: 9     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
  135. Lagast H, Zinner SH, Klastersky J. Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus. Antimicrob Agents Chemother. 1981 Oct; 20(4):539-41. PMID: 6282198.
    Citations: 7     Fields:    Translation:HumansCells
  136. Zinner SH, Husson M, Klastersky J. Effect of mixing on rifampin bactericidal activity against staphylococci. Antimicrob Agents Chemother. 1981 Aug; 20(2):267-9. PMID: 7283423.
    Citations: 5     Fields:    Translation:Cells
  137. McCormack WM, Evrard JR, Laughlin CF, Rosner B, Alpert S, Crockett VA, McComb D, Zinner SH. Sexually transmitted conditions among women college students. Am J Obstet Gynecol. 1981 Jan 15; 139(2):130-3. PMID: 6779634.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  138. Klastersky J, Gaya H, Zinner SH, Bernard C, Ryff JC. Cefotaxime and amikacin: results of in vitro and in vivo studies against Gram-negative bacteria and Staphylococcus aureus. EORTC International Antimicrobial Therapy Project Group. J Antimicrob Chemother. 1980 Sep; 6 Suppl A:55-61. PMID: 6252180.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  139. Zinner SH, Lee YH, Rosner B, Oh W, Kass EH. Factors affecting blood pressures in newborn infants. Hypertension. 1980 Jul-Aug; 2(4 Pt 2):99-101. PMID: 7399650.
    Citations: 1     Fields:    Translation:Humans
  140. McComb DE, Nichols RL, Semine DZ, Evrard JR, Alpert S, Crockett VA, Rosner B, Zinner SH, McCormack WM. Chlamydia trachomatis in women: antibody in cervical secretions as a possible indicator of genital infection. J Infect Dis. 1979 Jun; 139(6):628-33. PMID: 448189.
    Citations: 20     Fields:    Translation:HumansCells
  141. McCormack WM, Alpert S, McComb DE, Nichols RL, Semine DZ, Zinner SH. Fifteen-month follow-up study of women infected with Chlamydia trachomatis. N Engl J Med. 1979 Jan 18; 300(3):123-5. PMID: 758599.
    Citations: 43     Fields:    Translation:HumansCells
  142. Zinner SH, Margolius HS, Rosner B, Kass EH. Stability of blood pressure rank and urinary kallikrein concentration in childhood: an eight-year follow-up. Circulation. 1978 Nov; 58(5):908-15. PMID: 699259.
    Citations: 23     Fields:    Translation:Humans
  143. Schimpff SC, Gaya H, Klastersky J, Tattersall MH, Zinner SH. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group. J Infect Dis. 1978 Jan; 137(1):14-29. PMID: 624850.
    Citations: 49     Fields:    Translation:HumansCellsCTClinical Trials
  144. McCormack WM, Hayes CH, Rosner B, Evrard JR, Crockett VA, Alpert S, Zinner SH. Vaginal colonization with Corynebacterium vaginale (Haemophilus vaginalis). J Infect Dis. 1977 Dec; 136(6):740-5. PMID: 303656.
    Citations: 35     Fields:    Translation:HumansCells
  145. Parsley TL, Provonchee RB, Glicksman C, Zinner SH. Synergistic activity of trimethoprim and amikacin against gram-negative bacilli. Antimicrob Agents Chemother. 1977 Sep; 12(3):349-52. PMID: 410362.
    Citations: 9     Fields:    Translation:Cells
  146. Baker CJ, Goroff DK, Alpert S, Crockett VA, Zinner SH, Evrard JR, Rosner B, McCormack WM. Vaginal colonization with group B streptococcus: a study in college women. J Infect Dis. 1977 Mar; 135(3):392-7. PMID: 321702.
    Citations: 26     Fields:    Translation:HumansCells
  147. Kass EH, Rosner B, Zinner SH, Margolius HS, Lee YH. Studies on the origin of human hypertension. Postgrad Med J. 1977; 53 Suppl 2:145-52. PMID: 882473.
    Citations: 1     Fields:    Translation:Humans
  148. Zinner SH, Margolius HS, Rosner B, Keiser HR, Kass EH. Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes. Am J Epidemiol. 1976 Aug; 104(2):124-32. PMID: 952282.
    Citations: 17     Fields:    Translation:Humans
  149. Tarr PI, Lee YH, Alpert S, Schumacher JR, Zinner SH, McCormack WM. Comparison of methods for the isolation of genital mycoplasmas from men. J Infect Dis. 1976 Apr; 133(4):419-23. PMID: 772129.
    Citations: 5     Fields:    Translation:HumansCells
  150. Zinner SH, Provonchee RB, Elias KS, Peter G. Effect of clindamycin on the in vitro activity of amikacin and gentamicin against gram-negative bacilli. Antimicrob Agents Chemother. 1976 Apr; 9(4):661-4. PMID: 817663.
    Citations: 5     Fields:    Translation:Cells
  151. Zinner SH, McCabe WR. Gram-negative rod bacteremia in cancer patients. A review with emphasis on the antibody response. Eur J Cancer. 1975 Aug; 11suppl:39-47. PMID: 815091.
    Citations:    Fields:    Translation:HumansCells
  152. Zinner SH, Martin LF, Sacks F, Rosner B, Kass EH. A longitudinal study of blood pressure in childhood. Am J Epidemiol. 1974 Dec; 100(6):437-42. PMID: 4447107.
    Citations: 14     Fields:    Translation:Humans
  153. McCormack WM, Alpert S, Crockett VA, Zinner SH. Evaluation of self-obtained cultures using a vaginal tampon as a method of screening for asymptomatic gonorrhea on a college campus. J Am Vener Dis Assoc. 1974 Dec; 1(2):85-7. PMID: 4217785.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  154. Zinner SH, Daly AK, McCormack WM. Isolation of Eikenella corrodens in a general hospital. Appl Microbiol. 1973 May; 25(5):705-8. PMID: 4715552.
    Citations: 9     Fields:    Translation:HumansCells
  155. McCormack WM, Lee YH, Zinner SH. Sexual experience and urethral colonization with genital mycoplasmas. A study in normal men. Ann Intern Med. 1973 May; 78(5):696-8. PMID: 4711774.
    Citations: 16     Fields:    Translation:HumansCells
  156. Zinner SH, McCormack WM, Lee YH, Zuckerstatter MH, Daly AK. Puerperal bacteremia and neonatal sepsis due to Hemophilus parainfluenzae: report of a case with antibody titers. Pediatrics. 1972 Apr; 49(4):612-4. PMID: 4552108.
    Citations: 3     Fields:    Translation:HumansCells
  157. Bach MC, Zinner SH, Wilcox C, Finland M. Efficacy of standard disc-diffusion test as applied to susceptibility of Staphylococcus aureus to tetracycline and minocycline. J Lab Clin Med. 1972 Feb; 79(2):316-25. PMID: 5009717.
    Citations: 3     Fields:    Translation:Cells
  158. Zinner SH, Sabath LD, Casey JI, Finland M. Erythromycin and alkalinisation of urine in the treatment of urinary-tract infections due to gram-negative bacilli. Lancet. 1971 Jun 19; 1(7712):1267-8. PMID: 4104718.
    Citations: 5     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Zinner's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (334)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.